Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial. - Wikidata - wikimedia - TriplyDB

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.

http://www.wikidata.org/entity/Q33587199

about

Disseminated tumor cells and dormancy in prostate cancer metastasis Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence Bisphosphonate and risk of cancer recurrence: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma Bone-targeted therapy in metastatic breast cancer - all well-established knowledge?Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors.Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?Reproductive hormones in breast cancer bone metastasis: The role of inhibins.A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.The biology and clinical implications of prostate cancer dormancy and metastasis.Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets.Circulating and disseminated tumor cells: harbingers or initiators of metastasis?Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer - An AZURE (BIG 01/04) sub-study.Treatment of Minimal Residual Disease in Breast Cancer: A Longitudinal Case Study.Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up.Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer.Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse.Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment.

P2860

Q26768484-AEF31F5F-3441-4E64-8A75-581A51AA6E3C Q26795493-108CC02A-8199-4893-8988-E4AD44AD5EC3 Q26861586-4960ED25-3214-4706-8102-CC76A72871B1 Q28081996-DD33B90F-DA29-4D6F-B201-936B7D580E5E Q28087676-EE7780B8-7653-4F7D-A394-2225D6DF6DB8 Q34294905-D7B5EEC9-6DF5-4944-AC92-E1C0A4ACA90D Q35632622-97A073AD-F4C9-42A0-9716-FD12C8C385AB Q36574920-AEA6A83B-1C66-45A9-A3D9-74FDDAE10577 Q36925557-95A0620A-C182-4730-B0D9-7A224CB16876 Q37337495-01F63EF8-CB5B-43B9-A32B-E5384B33CDFE Q37656386-E1CC748D-067E-417B-BCD2-59763FDA2A69 Q38213416-D1CD083E-18A0-4A32-A220-3C6DAC1892DE Q38613304-C72C6109-FF84-4700-9D85-3CC9A354AC53 Q38716256-67B2BD8E-9989-4630-81F5-BF7C77202FA6 Q38770774-36311030-84CE-4197-999F-80C6201756BC Q39138688-9F8A601F-FE75-4A70-BAFE-8C864EB09927 Q47110989-1F637F93-A0D3-48AF-999C-7B151BBAA9EE Q47703368-98152E56-714C-4C4A-B124-2A07CE2A54F6 Q48185674-D8899734-9F08-494B-BC92-C7675F618392 Q49645514-7888D72B-D5AC-4844-87B9-830AA35A0EC9 Q51121871-00AA91BA-9E0E-4D67-8EBE-38810A743CCB Q53571768-76456F06-EBD6-4674-8482-8F7ABD07A6FF Q54240388-D953362D-9384-43C1-B8DA-7D35CA5C6EDB

P2860

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.

http://www.wikidata.org/entity/Q33587199

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Influence of zoledronic acid o ...... a prospective clinical trial.

@ast

Influence of zoledronic acid o ...... a prospective clinical trial.

@en

Influence of zoledronic acid o ...... a prospective clinical trial.

@nl

type

label

Influence of zoledronic acid o ...... a prospective clinical trial.

@ast

Influence of zoledronic acid o ...... a prospective clinical trial.

@en

Influence of zoledronic acid o ...... a prospective clinical trial.

@nl

prefLabel

Influence of zoledronic acid o ...... a prospective clinical trial.

@ast

Influence of zoledronic acid o ...... a prospective clinical trial.

@en

Influence of zoledronic acid o ...... a prospective clinical trial.

@nl

P1433

Q33587199-284683BE-9A69-4F90-8CC4-778BA4A388B0

P1476

Q33587199-EC9340D5-C5C3-454D-B703-40BAF7517E91

P2093

Q33587199-2A863C0E-4D74-452D-8ED8-149829FC0EBD

Q33587199-59E895F6-A256-4D0A-ABEF-E07F06838C23

Q33587199-5F8B21A9-DD02-4775-B163-D51C2DBA794A

Q33587199-6E8E0554-3F86-408F-BDF3-2A47DCCE6405

Q33587199-8648C800-90B5-45B4-90E9-DC6B1E550C86

Q33587199-B70F2101-EA07-4050-A076-EAE2D893D823

Q33587199-C393C86A-7EF3-40D7-A3E6-A16AED8FBC6C

Q33587199-EB88CD24-2998-4C7D-BF83-6273BA534576

P2860

Q33587199-020529B4-CD9D-478F-91E2-28FE27B33A27

Q33587199-0548873D-C00D-456A-8738-B3D051307658

Q33587199-10C0822E-0169-4ECC-92D8-A1860FBC3735

Q33587199-1B69FCEE-CF5B-4F47-9A4E-BF2FDA393D0C

Q33587199-26842C12-F9F0-44B7-A14B-D67BFE169226

Q33587199-280431C0-C534-45A5-AD71-07CA7CA03607

Q33587199-2AED5177-3205-4FF6-A5F5-DC5A64EB4D1B

Q33587199-3C423EB8-F448-4ABB-AC2B-2664D702BBF1

Q33587199-5D04EC47-18AA-4FF7-8CED-FAD19CF4568D

Q33587199-65680CA1-685A-408D-B967-B7DFB634C392

P2888

Q33587199-A22F7961-1F95-4B09-AD82-B46A6D80D506

P304

Q33587199-7224B788-5498-4666-BEC3-5BBB1E487BC5

P31

Q33587199-7D0C86D0-6375-42FD-9A8F-78289D7F5C25

P356

Q33587199-151B604D-A396-406C-973D-414FC60C47C0

P407

Q33587199-22D254CA-F902-4A25-BDC1-2382137D7CEC

P478

Q33587199-ABFD58DD-935C-4295-8E8B-C95A4A8727F3

P50

Q33587199-2CE108AB-BF52-4B95-A50B-CEB52B6C520E

Q33587199-36C0BFE7-0A69-4F88-9AE5-C6447A32CFF2

Q33587199-7FA5AA5F-54A5-44DB-87F7-82493A0A1719

Q33587199-D9C514E3-C710-436A-9010-96083824D581

Q33587199-F2C1AD20-CC9F-4A66-8824-44F2A2B3ED47

P577

Q33587199-45E3C41B-1654-4C26-9324-379139B3F55B

P5875

Q33587199-368E2046-7C8E-4EB1-8165-44F68DAB53B1

P6179

Q33587199-2A9CC072-CE61-4C4C-8AFE-EB435F3D9AD7

P698

Q33587199-283E038F-B27F-4FA1-BBE8-FDA1DAF22A47

P921

Q33587199-7A628A1F-876B-4E44-8C35-6EFC6991CC43

P932

Q33587199-F982C25A-F3E9-48C5-BE76-6A149DF330FE

P356

1471-2407-13-480

P1433

P1476

Influence of zoledronic acid o ...... a prospective clinical trial.

@en

P2093

Bernhard Kraemer

http://www.w3.org/2001/XMLSchema#string

Birgit Wackwitz

http://www.w3.org/2001/XMLSchema#string

Gerhard Gebauer

http://www.w3.org/2001/XMLSchema#string

Hans-Joachim Lueck

http://www.w3.org/2001/XMLSchema#string

Natalia Krawczyk

http://www.w3.org/2001/XMLSchema#string

Peter Hirnle

http://www.w3.org/2001/XMLSchema#string

Sven Becker

http://www.w3.org/2001/XMLSchema#string

Wolfgang Janni

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Bisphosphonates induce apoptosis in human breast cancer cell lines

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.

How do bisphosphonates inhibit bone metastasis in vivo?

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.

The metastatic niche: adapting the foreign soil.

Exploring the anti-tumour activity of bisphosphonates in early breast cancer.

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up.

P2888

1471-2407-13-480

P304

480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-480

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Diethelm Wallwiener

Erich-Franz Solomayer

Malgorzata Banys

P577

2013-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257837733

http://www.w3.org/2001/XMLSchema#string

P6179

1003661571

http://www.w3.org/2001/XMLSchema#string

P698

24128322

http://www.w3.org/2001/XMLSchema#string

P921

P932

4015285

http://www.w3.org/2001/XMLSchema#string